Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

NCT01404936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Interferon-2A
DRUG: Adriamycin
DRUG: Bleomycin
DRUG: Velban
DRUG: Dacarbazine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]